Amy Kluge

429 total citations
13 papers, 349 citations indexed

About

Amy Kluge is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Kluge has authored 13 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Kluge's work include RNA modifications and cancer (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Amy Kluge is often cited by papers focused on RNA modifications and cancer (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Amy Kluge collaborates with scholars based in United States and Germany. Amy Kluge's co-authors include Afshin Dowlati, Ramesh Ramakrishnan, Robert C. Jones, Weiwen Fan, Zhe Tang, Jun Wang, Gary Wildey, C. Patrick, Michael Yang and Adam Kresak and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Amy Kluge

13 papers receiving 344 citations

Peers

Amy Kluge
Binya Liu China
Rachel Joyce Australia
Qianyi Lu China
Jiali Wu China
Conan G. Kinsey United States
Binya Liu China
Amy Kluge
Citations per year, relative to Amy Kluge Amy Kluge (= 1×) peers Binya Liu

Countries citing papers authored by Amy Kluge

Since Specialization
Citations

This map shows the geographic impact of Amy Kluge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kluge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kluge more than expected).

Fields of papers citing papers by Amy Kluge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kluge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kluge. The network helps show where Amy Kluge may publish in the future.

Co-authorship network of co-authors of Amy Kluge

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Kluge. A scholar is included among the top collaborators of Amy Kluge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Kluge. Amy Kluge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Babakoohi, Shahab, Amy Kluge, James J. Morrow, et al.. (2014). RET Mutation and Expression in Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(9). 1316–1323. 38 indexed citations
2.
Kluge, Amy, Adam Kresak, Michael Yang, et al.. (2014). Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival. Clinical Cancer Research. 20(19). 5124–5132. 36 indexed citations
3.
Kluge, Amy, Karen McColl, Yu Liu, et al.. (2013). PIAS3 activates the intrinsic apoptotic pathway in non‐small cell lung cancer cells independent of p53 status. International Journal of Cancer. 134(5). 1045–1054. 12 indexed citations
4.
Kluge, Amy, et al.. (2011). Protein inhibitor of activated STAT3 expression in lung cancer. Molecular Oncology. 5(3). 256–264. 36 indexed citations
5.
Kluge, Amy, et al.. (2011). Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors. Cancer Biology & Therapy. 12(2). 139–151. 9 indexed citations
6.
Kluge, Amy, et al.. (2011). Abstract 2932: Role of P53 in the negative regulatory function of PIAS3 with STAT3 in lung cancer. Cancer Research. 71(8_Supplement). 2932–2932. 1 indexed citations
7.
Wang, Jun, Ramesh Ramakrishnan, Zhe Tang, et al.. (2010). Quantifying EGFR Alterations in the Lung Cancer Genome with Nanofluidic Digital PCR Arrays. Clinical Chemistry. 56(4). 623–632. 81 indexed citations
9.
Kluge, Amy, et al.. (2009). The Association and Nuclear Translocation of the PIAS3-STAT3 Complex Is Ligand and Time Dependent. Molecular Cancer Research. 7(11). 1854–1860. 32 indexed citations
11.
Stein, Catherine M., Christopher J. Millard, Amy Kluge, et al.. (2007). Further Evidence of Pleiotropy Influencing Speech and Language: Analysis of the DYX8 Region. Human Heredity. 63(1). 47–58. 27 indexed citations
12.
Stein, Catherine M., Christopher J. Millard, Amy Kluge, et al.. (2006). Speech Sound Disorder Influenced by a Locus in 15q14 Region. Behavior Genetics. 36(6). 858–868. 41 indexed citations
13.
Iyengar, Sudha K., Scott A. Shaffer, Amy Kluge, et al.. (2005). Analysis of Mutations in the Gene for the Alpha 2 Chain of Type VIII Collagen (COL8A2) in Families and Cases With Fuchs’ Endothelial Corneal Dystrophy. Investigative Ophthalmology & Visual Science. 46(13). 4715–4715. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026